Jon P. Stonehouse - Dec 19, 2024 Form 4 Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role
President & CEO, Director
Signature
/s/ Alane P. Barnes, by power of attorney
Stock symbol
BCRX
Transactions as of
Dec 19, 2024
Transactions value $
-$103,534
Form type
4
Date filed
12/23/2024, 04:01 PM
Previous filing
Dec 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCRX Common Stock Award $0 +362K +32.89% $0.00 1.46M Dec 19, 2024 Direct F1
transaction BCRX Common Stock Tax liability -$104K -14K -0.96% $7.39 1.45M Dec 19, 2024 Direct F2
transaction BCRX Common Stock Gift $0 -20K -1.38% $0.00 1.43M Dec 20, 2024 Direct F3
transaction BCRX Common Stock Gift $0 +10K +50% $0.00 30K Dec 20, 2024 By wife as co-trustee of the Caroline Stonehouse Irrevocable Trust F3
transaction BCRX Common Stock Gift $0 +10K +50% $0.00 30K Dec 20, 2024 By wife as co-trustee of the Samuel Stonehouse Irrevocable Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCRX Emp. Stock Option (Right to Buy) Award $0 +750K $0.00 750K Dec 19, 2024 Common Stock 750K $7.39 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Annual award of Restricted Stock Units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant.
F2 Represents shares withheld by the Issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the Reporting Person.
F3 On December 20, 2024, the Reporting Person gifted 10,000 shares held directly by him to each of the Samuel Stonehouse Irrevocable Trust and the Caroline Stonehouse Irrevocable Trust.
F4 Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.